BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23625588)

  • 1. Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.
    Liang H; Kowalczyk P; Junco JJ; Klug-De Santiago HL; Malik G; Wei SJ; Slaga TJ
    Mol Carcinog; 2014 Sep; 53(9):753-63. PubMed ID: 23625588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
    Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB.
    Bougarne N; Paumelle R; Caron S; Hennuyer N; Mansouri R; Gervois P; Staels B; Haegeman G; De Bosscher K
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7397-402. PubMed ID: 19376972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of peroxisome proliferator-activated receptor-alpha expression during lung inflammation.
    Becker J; Delayre-Orthez C; Frossard N; Pons F
    Pulm Pharmacol Ther; 2008; 21(2):324-30. PubMed ID: 17897854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peroxisome proliferator-activated receptor alpha activator fenofibrate inhibits endothelin-1-induced cardiac fibroblast proliferation.
    Ogata T; Miyauchi T; Irukayama-Tomobe Y; Takanashi M; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S279-82. PubMed ID: 15838301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis.
    Zak Z; Gelebart P; Lai R
    Leukemia; 2010 Aug; 24(8):1476-86. PubMed ID: 20520642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.
    Wang W; Lin Q; Lin R; Zhang J; Ren F; Zhang J; Ji M; Li Y
    Exp Cell Res; 2013 Jun; 319(10):1523-33. PubMed ID: 23603572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose.
    Zanetti M; Stocca A; Dapas B; Farra R; Uxa L; Bosutti A; Barazzoni R; Bossi F; Giansante C; Tedesco F; Cattin L; Guarnieri G; Grassi G
    J Mol Med (Berl); 2008 Feb; 86(2):185-95. PubMed ID: 17876565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
    Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
    Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1.
    Ann SJ; Chung JH; Park BH; Kim SH; Jang J; Park S; Kang SM; Lee SH
    Atherosclerosis; 2015 Jun; 240(2):389-97. PubMed ID: 25881202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
    Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate.
    Osada M; Sakai T; Kuroyanagi K; Kohno H; Tsuneoka H
    Mol Vis; 2014; 20():1518-26. PubMed ID: 25489225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of budesonide on the expression of the glucocorticoid receptor-α in nasal polyp epithelial cells.
    Wang DS; Liu QS; Lai HC
    Am J Rhinol Allergy; 2013; 27(2):123-7. PubMed ID: 23562201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARα/AMPK/AKT/FoxO1 pathway.
    Wang MS; Han QS; Jia ZR; Chen CS; Qiao C; Liu QQ; Zhang YM; Wang KW; Wang J; Xiao K; Ding XS
    Acta Pharmacol Sin; 2022 Jan; 43(1):167-176. PubMed ID: 33772142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate antagonizes Chk2 activation by inducing Wip1 expression: implications for cell proliferation and tumorigenesis.
    Joe Y; Do MH; Seo E; Kang S; Park HT; Yun J; Lee HJ
    Life Sci; 2010 May; 86(19-20):716-21. PubMed ID: 20226795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor alpha agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats.
    Chen X; Li M; Sun W; Bi Y; Cai M; Liang H; Yu Q; He X; Weng J
    Biochem Biophys Res Commun; 2008 Apr; 368(4):865-70. PubMed ID: 18267115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation.
    Tomizawa A; Hattori Y; Inoue T; Hattori S; Kasai K
    Metabolism; 2011 Apr; 60(4):513-22. PubMed ID: 20580385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity.
    Ishiguro H; Kawahara T; Zheng Y; Kashiwagi E; Li Y; Miyamoto H
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):249-55. PubMed ID: 24880571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARalpha activators upregulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation.
    Okayasu T; Tomizawa A; Suzuki K; Manaka K; Hattori Y
    Life Sci; 2008 Apr; 82(15-16):884-91. PubMed ID: 18346759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.